Alger Small Cap Growth A holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Alger Small Cap Growth Fund Class A ALSAX
- NAV / 1-Day Return 14.15 / +1.36 %
- Total Assets 208.2M
-
Adj. Expense Ratio
1.320%
- Expense Ratio 1.320%
- Distribution Fee Level Above Average
- Share Class Type Front Load
- Category Small Growth
- Investment Style Small Growth
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.00
- Turnover 38%
USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 12:53 AM GMT+0
Morningstar’s Analysis ALSAX
Will ALSAX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 25.9
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Cash | 5.93 | 12M | Cash and Equivalents |
Forte Biosciences Inc Ordinary Shares | 4.77 | 10M | Healthcare |
Tutor Perini Corp | 2.83 | 6M | Industrials |
Victoria's Secret & Co | 2.61 | 5M | Consumer Cyclical |
Adaptive Biotechnologies Corp | 2.46 | 5M | Healthcare |
Absci Corp | 2.45 | 5M | Healthcare |
RBC Bearings Inc | 2.34 | 5M | Industrials |
Twist Bioscience Corp | 2.27 | 5M | Healthcare |
CSW Industrials Inc | 2.26 | 5M | Industrials |
Gates Industrial Corp Ltd | 2.00 | 4M | Industrials |